Symmetry Peak Management LLC Purchases Shares of 5,000 DocuSign, Inc. (NASDAQ:DOCU)

Symmetry Peak Management LLC purchased a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 5,000 shares of the company’s stock, valued at approximately $297,000.

Other hedge funds have also added to or reduced their stakes in the company. Capital Analysts LLC lifted its stake in DocuSign by 781.7% in the fourth quarter. Capital Analysts LLC now owns 529 shares of the company’s stock valued at $31,000 after purchasing an additional 469 shares during the last quarter. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of DocuSign during the fourth quarter worth $32,000. Whittier Trust Co. raised its position in shares of DocuSign by 28.8% during the 4th quarter. Whittier Trust Co. now owns 935 shares of the company’s stock valued at $56,000 after buying an additional 209 shares in the last quarter. Desjardins Global Asset Management Inc. lifted its holdings in shares of DocuSign by 60.5% during the 4th quarter. Desjardins Global Asset Management Inc. now owns 966 shares of the company’s stock worth $57,000 after acquiring an additional 364 shares during the last quarter. Finally, Jones Financial Companies Lllp purchased a new position in DocuSign in the fourth quarter worth $59,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Trading Up 1.2 %

DocuSign stock traded up $0.63 during mid-day trading on Tuesday, hitting $51.62. The stock had a trading volume of 1,434,069 shares, compared to its average volume of 3,009,755. The firm has a market capitalization of $10.60 billion, a P/E ratio of 98.06, a P/E/G ratio of 4.50 and a beta of 0.89. The firm’s 50 day moving average is $57.57 and its 200 day moving average is $56.34. DocuSign, Inc. has a one year low of $38.11 and a one year high of $64.76.

Insider Buying and Selling

In other DocuSign news, Director Teresa Briggs sold 499 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $54.92, for a total value of $27,405.08. Following the sale, the director now owns 6,668 shares in the company, valued at approximately $366,206.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, Director Teresa Briggs sold 499 shares of the company’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $54.92, for a total transaction of $27,405.08. Following the sale, the director now directly owns 6,668 shares in the company, valued at approximately $366,206.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Allan C. Thygesen sold 8,086 shares of the stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $56.16, for a total transaction of $454,109.76. Following the sale, the chief executive officer now directly owns 99,546 shares of the company’s stock, valued at approximately $5,590,503.36. The disclosure for this sale can be found here. In the last quarter, insiders sold 47,512 shares of company stock valued at $2,746,767. Company insiders own 1.66% of the company’s stock.

Analyst Upgrades and Downgrades

DOCU has been the subject of several research analyst reports. Robert W. Baird dropped their price target on DocuSign from $65.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday. Morgan Stanley reduced their price objective on DocuSign from $65.00 to $62.00 and set an “equal weight” rating on the stock in a research note on Friday. Piper Sandler lowered their target price on DocuSign from $65.00 to $60.00 and set a “neutral” rating for the company in a research note on Friday. Royal Bank of Canada cut their price objective on DocuSign from $59.00 to $52.00 and set a “sector perform” rating on the stock in a research report on Friday. Finally, UBS Group raised DocuSign from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $48.00 to $62.00 in a research report on Friday, April 12th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, DocuSign presently has an average rating of “Hold” and an average target price of $59.36.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.